Related Experiment Video
Updated: Dec 26, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Alberto J Lorenzatti1,2, Peter P Toth3,4
1DAMIC Medical Institute, Rusculleda Foundation for Research, Cordoba, Argentina.
Insights
Atherogenic dyslipidemia, marked by high triglycerides and low HDL cholesterol, significantly increases cardiovascular disease risk. Lifestyle changes and medications can manage these lipid abnormalities to reduce residual risk.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Lipidology
Background:
- Atherogenic dyslipidemia is a prevalent lipid abnormality strongly linked to cardiovascular disease (CVD) risk.
- Despite statin and non-statin therapies, residual CVD risk persists due to non-LDL cholesterol patterns.
- These patterns include elevated triglycerides, low HDL cholesterol, small dense LDL particles, and postprandial hyperlipidaemia.
Purpose of the Study:
- To review the pathophysiology of atherogenic dyslipidemia.
- To explore its association with atherosclerotic cardiovascular disease development.
- To outline therapeutic strategies for managing these lipid alterations and preventing CVD events.
Main Methods:
- Literature review of pathophysiology.
- Analysis of the relationship between lipid profiles and atherosclerosis.
- Summary of current lifestyle and pharmacological interventions.
Main Results:
- Atherogenic dyslipidemia is associated with insulin resistance, type 2 diabetes, and obesity.
- These lipid modifications contribute to increased atherosclerotic cardiovascular disease risk.
- Therapeutic approaches involve lifestyle modifications and pharmacological treatments.
Conclusions:
- Atherogenic dyslipidemia represents a significant challenge in cardiovascular disease prevention.
- Understanding its pathophysiology is crucial for effective management.
- A combination of lifestyle changes and targeted therapies is necessary to mitigate residual cardiovascular risk.
Abstract:
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an increased risk of cardiovascular (CV) disease. Despite the excellent results achieved from statin and non-statin management of LDL cholesterol and CV events prevention, there still remains a significant residual risk, associated with the prevalence of non-LDL cholesterol lipid patterns characterised by elevated triglyceride levels, low HDL cholesterol, a preponderance of small and dense LDL particles, accumulation of remnant lipoproteins and postprandial hyperlipidaemia. These qualitative and quantitative lipid modifications are largely associated with insulin resistance, type 2 diabetes and obesity, the prevalence of which has grown to epidemic proportions throughout the world. In this review, we analyse the pathophysiology of this particular dyslipidaemia, its relationship with the development of atherosclerotic CV disease and, finally, briefly describe the therapeutic approaches, including changes in lifestyle and current pharmacological interventions to manage these lipid alterations aimed at preventing CV events.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...